A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-26

Study Completion Date

2024-09-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experiencing self-perceived hair thinning.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin

NCT06579742

Hair Thinning Hair Loss

ACTIVE_NOT_RECRUITING NA

Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females

NCT03052413

Hair Loss

COMPLETED NA

Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females

NCT06376409

Hair Thinning

COMPLETED NA

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

NCT06146166

Hair Thinning

ACTIVE_NOT_RECRUITING NA

Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men

NCT06362941

Hair Thinning

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hair Thinning Hair Shedding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Participants in this arm will take the Scale HLV Clinical Formula Hair Vitamins.

Group Type EXPERIMENTAL

Scale HLV Clinical Formula Hair Vitamins

Intervention Type DIETARY_SUPPLEMENT

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Placebo

Participants in this arm will take a placebo product consisting of rice flour in vegetable cellulose capsules.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Scale HLV Clinical Formula Hair Vitamins

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Intervention Type DIETARY_SUPPLEMENT

Placebo

For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female at birth, aged 35+.
* Self-perceived hair thinning and increased hair shedding for at least three months.
* Consistent hair care routine for at least one month prior.
* Willing to maintain hair care routine, diet, and refrain from new vitamins or supplements targeting hair growth during the study.
* Generally healthy without uncontrolled chronic diseases.

Exclusion Criteria

* Hair loss conditions other than female pattern baldness.
* Pregnant, breastfeeding, or trying to conceive.
* Currently taking iron supplements or other hair growth treatments.
* Significant chronic conditions or planned medical procedures that interfere with protocol adherence.
* Recent chemical hair treatments or plans for such treatments during the study.
* Severe allergic reactions to the product's ingredients.
* Recent surgeries, major illnesses, or undergoing chemotherapy/radiotherapy.

Minimum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No